S

Schuster Medical Research Institute | Sherman Oaks, CA

Research site

(Unclaimed)

Location

5000 Van Nuys Boulevard, Suite 216, Sherman Oaks, California, United States of America

Site insights

Top conditions

Top treatments

SEP-363856

KarXT

Cariprazine

Bapineuzumab

Atogepant

BMS-820836

Lasmiditan

MK-8189

Aripiprazole

Leuco-methylthioninium Bis(Hydromethanesulfonate)

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 37 total trials

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder. This study will be accept...

Enrolling

Generalized Anxiety Disorder

Drug: Placebo

Drug: SEP-363856

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic o...

Active, not recruiting

Chronic Migraine

Episodic Migraine

Drug: Atogepant 60 mg

A Trial of the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia

This is a Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Determine the the Efficacy and Safety of SEP-363856 in Acutely...

Enrolling

Schizophrenia

Drug: SEP-363856

Other: Placebo